DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lifevantage Corporation (LXRX)
« Back to company indexLXRX Chatter Timeline
Stock Ticker for LXRX
Most Active Tweeters for LXRX
| User | Tweets |
|---|---|
| @AmericanBanking | 4 |
| @ConsumerFeed | 1 |
| @SleekMoneycom | 1 |
| @RTradesCapital | 1 |
| @ez_alertz | 1 |
Recent Tweets for LXRX
 |
@ez_alertz $LXRX AstraZeneca's Farxiga Gets CRL from FDA for Type I Diabetes https://t.co/XYbBzyJWw9 July 15th 2019, 6:07pm |
 |
@AmericanBanking Brokerages Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $24.66 Million https://t.co/3MqbQc8ggb #stocks July 15th 2019, 2:07am |
|
@AmericanBanking Lexicon Pharmaceuticals, Inc. $LXRX Sees Large Growth in Short Interest https://t.co/G5mw9NNmSi #stocks July 14th 2019, 12:07pm |
|
@AmericanBanking -$0.09 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/acAkQPyVII #stocks July 13th 2019, 6:07pm |
 |
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Stock Price Passes Above 50 Day Moving Average of $5.89 https://t.co/PzMWkyqMKW July 12th 2019, 1:07pm |
|
@AmericanBanking Lexicon Pharmaceuticals, Inc. $LXRX Given Average Recommendation of “Hold” by Analysts https://t.co/YoVZGNvrxB #stocks July 12th 2019, 4:07am |
 |
@TheMarketsDaily Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/n9kgBp6TTJ July 7th 2019, 5:07am |
 |
@storminvestor Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/qiKhJciC8c #markets July 7th 2019, 5:07am |
 |
@macondailynews Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/ZizLBHFtcZ July 7th 2019, 5:07am |
 |
@stocknewstimes Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/X47lML5ibl July 7th 2019, 5:07am |
 |
@SleekMoneycom Zacks Investment Research Lowers Lexicon Pharmaceuticals $LXRX to Hold https://t.co/ZFpmjHpdeo #investing July 7th 2019, 5:07am |
 |
@ZolmaxNews Lexicon Pharmaceuticals $LXRX Rating Lowered to Hold at Zacks Investment Research https://t.co/i8GV9gUC8X July 5th 2019, 2:07am |
 |
@TickerReport Lexicon Pharmaceuticals $LXRX Cut to “Hold” at Zacks Investment Research https://t.co/i31fGTryO8 July 5th 2019, 2:07am |
 |
@BeefEnt Lexicon Pharmaceuticals Inc NASDAQ: $LXRX Health Care : Biotechnology | Small Cap Growth Company profile BuySell Closing Price $6.36 July 4th 2019, 10:07am |
 |
@Gambiste1 RT @RTradesCapital: $LXRX low float stock. Ready for some PRs. July 3rd 2019, 4:07pm |
 |
@Tickeron A.I.dvisor made a bullish call on $LXRX, netting in a 17.88% gain over 2 weeks https://t.co/SZEJnD1cqK https://t.co/xzHGU5OmIM July 3rd 2019, 2:07pm |
 |
@RTradesCapital $LXRX low float stock. Ready for some PRs. July 3rd 2019, 10:07am |
 |
@ResearchPool $LXRX #Lexicon Pharmaceuticals Inc Maintaining Our Lexicon FVE Following Zynquistas Europe Approval and Modest 1Q X… https://t.co/srgVuREsU4 July 1st 2019, 7:07pm |
|
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub to “Sell” https://t.co/s1goyz3dro July 1st 2019, 3:07am |
 |
@IRAMarketReport Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub to “Sell” https://t.co/9zYNSDFF3w #markets July 1st 2019, 3:07am |
 |
@chaffeybreeze Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub to “Sell” https://t.co/zRdXyo85n2 #stocks July 1st 2019, 3:07am |
 |
@ThisLincolnian Lexicon Pharmaceuticals $LXRX Cut to Sell at BidaskClub https://t.co/WW0jTG5l5w June 30th 2019, 8:06am |
 |
@bbnsnews Lexicon Pharmaceuticals $LXRX Cut to Sell at BidaskClub https://t.co/Xystsr9wUZ June 30th 2019, 8:06am |
|
@TickerReport Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub https://t.co/y7R5lFFFY1 June 28th 2019, 10:06am |
 |
@OlympiaReport Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/fk9asrPv9b June 27th 2019, 4:06pm |
 |
@dispatchtribune -$0.09 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/U3v7Eqt6FG June 27th 2019, 4:06pm |
 |
@registrarjourn Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/gXC4k31uBf June 27th 2019, 4:06pm |
 |
@EnterpriseLeade Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/4Uns2uPg4G June 27th 2019, 4:06pm |
|
@ThisLincolnian Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $24.66 Million https://t.co/SxAOuUMQTi June 27th 2019, 4:06pm |
 |
@WeekHerald Analysts Anticipate Lexicon Pharmaceuticals, Inc. $LXRX Will Post Quarterly Sales of $24.66 Million https://t.co/iSJD322Qej June 27th 2019, 4:06pm |
 |
@ProVesting $LXRX $CMRE: Here is What Hedge Funds Think About Lexicon Pharmaceuticals …: https://t.co/sLj8OY8i8N June 26th 2019, 2:06pm |
 |
@tradnews_ RT @TrendSpider: $LXRX when in doubt, create bi-directional price alerts, and go relax :) https://t.co/GQBo2wWbmS June 26th 2019, 12:06am |
 |
@TrendSpider $LXRX when in doubt, create bi-directional price alerts, and go relax :) https://t.co/GQBo2wWbmS June 25th 2019, 11:06pm |
|
@TickerReport Zacks: Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX to Post -$0.09 EPS https://t.co/KOF97hCpgv June 25th 2019, 9:06am |
|
@TheMarketsDaily BidaskClub Upgrades Lexicon Pharmaceuticals $LXRX to “Hold” https://t.co/iXg9NLiuMC June 24th 2019, 2:06am |
|
@macondailynews BidaskClub Upgrades Lexicon Pharmaceuticals $LXRX to “Hold” https://t.co/Ui37Vb0Hx3 June 24th 2019, 2:06am |
|
@OlympiaReport Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/hOkJWwz8Dn June 23rd 2019, 8:06am |
|
@ThisLincolnian Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/mt0WMvEyqd June 23rd 2019, 8:06am |
|
@WeekHerald BidaskClub Upgrades Lexicon Pharmaceuticals $LXRX to “Hold” https://t.co/EdKFjjdGVU June 23rd 2019, 8:06am |
|
@TickerReport Brokerages Set Lexicon Pharmaceuticals, Inc. $LXRX Target Price at $16.38 https://t.co/BPaRhLmj7W June 22nd 2019, 3:06pm |
 |
@dakotafinancial Brokerages Set Lexicon Pharmaceuticals, Inc. $LXRX Target Price at $16.38 https://t.co/2Y24UGnCbj June 22nd 2019, 3:06pm |
|
@AmericanBanking Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $24.66 Million https://t.co/SwOa77cBNA #stocks June 22nd 2019, 2:06am |
|
@TickerReport Lexicon Pharmaceuticals $LXRX Upgraded by BidaskClub to “Hold” https://t.co/DBEV8B4BNw June 21st 2019, 9:06am |
 |
@SwingTradeBot Fell Below 50 DMA today: $LXRX ... https://t.co/j2lcQOTpfA June 20th 2019, 4:06pm |
|
@AmericanBanking Analysts Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Post Earnings of -$0.09 Per Share https://t.co/6vBu9medX8 #stocks June 20th 2019, 2:06pm |
|
@AmericanBanking Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Drops By 20.5% https://t.co/OdFymTysq8 #stocks June 17th 2019, 12:06pm |
|
@AmericanBanking Lexicon Pharmaceuticals, Inc. $LXRX Receives Average Rating of “Hold” from Analysts https://t.co/AHpMYRy3gM #stocks June 17th 2019, 4:06am |
|
@WeekHerald Lexicon Pharmaceuticals, Inc. $LXRX Receives Consensus Rating of “Hold” from Analysts https://t.co/QOFEvKLPCQ June 17th 2019, 4:06am |
 |
@midetimes Lexicon Pharmaceuticals $LXRX Given a $35.00 Price Target at Wedbush https://t.co/wQuyfnDCj2 #stocks June 15th 2019, 3:06am |
 |
@dailymailtimes Lexicon Pharmaceuticals $LXRX Given a $35.00 Price Target at Wedbush https://t.co/pHO3bVp4aR #investing June 15th 2019, 3:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.